Home › NDC Lookup › RxCUI directory › RxCUI 2734137

Meclizine hydrochloride 50 MG Oral Powder [Dramamine Less Drowsy] — RxCUI 2734137

RxNorm drug concept · Semantic branded drug
RxCUI 2734137 Semantic branded drug · SBD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2734137
Official nameMeclizine hydrochloride 50 MG Oral Powder [Dramamine Less Drowsy]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asDramamine Less Drowsy 50 MG Oral Powder
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Meclizine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Meclizine is mainly used to prevent and treat the nausea, vomiting, and dizziness that comes with motion sickness — whether you're on a boat, in a car, or on a plane. It's also use...
  • For the best chance of preventing motion sickness, take meclizine about one hour before you start traveling. After that first dose, you can take it once every 24 hours as needed fo...
  • Yes, drowsiness is the most common side effect — it's actually worth planning around. Avoid driving or operating heavy machinery until you know how it affects you. And definitely s...
  • This one requires a conversation with your doctor. Human studies haven't clearly linked meclizine to birth defects, but animal studies did show fetal harm at doses similar to what...
📖 Read our full Meclizine guide →

🕸️ Concept Web — How Meclizine hydrochloride 50 MG Oral Powder [Drama... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Meclizine hydrochloride 50 MG Oral Powder [Dramamine Less Drowsy] RxCUI 2734137

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Meclizine 6676
    • Meclizine hydrochloride 82041
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Dramamine Less Drowsy 827176
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Meclizine Oral Powder 2734129
    • Meclizine hydrochloride Oral Powder 2734131
    • Meclizine Oral Powder Product 2734128
    • Meclizine Oral Product 1159177
    • Meclizine hydrochloride Oral Powder Product 2734130
    • Meclizine hydrochloride Oral Product 2659152
    • Meclizine Oral Powder [Dramamine Less Drowsy] 2734135
    • Meclizine hydrochloride Oral Powder [Dramamine Less Drowsy] 2734136
    • +5 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Meclizine hydrochloride 50 MG Oral Powder SCD · 2734132
  • Meclizine hydrochloride 50 MG SCDC · 995685
  • Meclizine Oral Powder SCDF · 2734129
  • Meclizine hydrochloride Oral Powder SCDFP · 2734131
  • Meclizine Oral Powder Product SCDG · 2734128
  • Meclizine Oral Product SCDG · 1159177
  • Meclizine hydrochloride Oral Powder Product SCDGP · 2734130
  • Meclizine hydrochloride Oral Product SCDGP · 2659152

Brand-Name Concepts

  • Meclizine hydrochloride 50 MG [Dramamine Less Drowsy] SBDC · 2734133
  • Meclizine Oral Powder [Dramamine Less Drowsy] SBDF · 2734135
  • Meclizine hydrochloride Oral Powder [Dramamine Less Drowsy] SBDFP · 2734136
  • Dramamine Less Drowsy Oral Powder Product SBDG · 2734134
  • Dramamine Less Drowsy Oral Product SBDG · 1175931
  • Dramamine Less Drowsy BN · 827176

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 2734137 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
63029-0912-04 4 POWDER in 1 BOX (63029-912-04) DRAMAMINE Medtech Products Inc. 2026-02-02
Observed labelers: Medtech Products Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.